Occudo Quantitative Strategies LP Cytosorbents Corp Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $10,721 - $19,616	6,092 Added 33.34%	24,367 $53,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $2,416 - $3,548	-839 Reduced 4.39%	18,275 $58,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $12,951 - $25,935	-3,198 Reduced 14.33%	19,114 $80,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $15,967 - $22,148	2,281 Added 11.39%	22,312 $181,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $24,394 - $30,436	3,231 Added 19.23%	20,031 $151,000
Q1 2021 May 14, 2021	BUY	$8.23 - $11.48 $138,264 - $192,864	16,800 New	16,800 $146,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.